Unveiling the anti-cancer mechanism for half-sandwich and cyclometalated Ir(iii)-based complexes with functionalized alpha-lipoic acid

Wang, MM (Wang, Meng-Meng)[ 1 ] ; Xue, XL (Xue, Xu-Ling)[ 1 ] ; Sheng, XX (Sheng, Xi-Xi)[ 1 ] ; Su, Y (Su, Yan)[ 1 ] ; Kong, YQ (Kong, Ya-Qiong)[ 1 ] ; Qian, Y (Qian, Yong)[ 1 ] ; Bao, JC (Bao, Jian-Chun)[ 1 ] ; Su, Z (Su, Zhi)[ 1 ]*（苏志） ; Liu, HK (Liu, Hong-Ke)[ 1 ]*（刘红科）

[ 1 ] Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Collaborat Innovat Ctr Biomed Funct Mat, Nanjing 210023, Peoples R China

RSC ADVANCES，202002,10(9),5392-5398

Alpha lipoic acid (LA) is a natural compound and coenzyme with sufficient safety information for serving as a promising anticancer agent. To further clarify the mechanism of action (MoA), two Ir(iii) complexes with the functionalized alpha-lipoic acid ((NN)-N-boolean AND-LA, (NN)-N-boolean AND, 2,2-bipyridine derivative), namely Ir1 and Ir2, were synthesized, where Ir1 possessed a half-sandwich structure with the formula [Ir(Cp*)((NN)-N-boolean AND-LA)Cl]PF6 (Cp* = 1,2,3,4,5-pentamethyl-cyclopentadiene) and Ir2 possessed the cyclometalated structure with the formula [Ir((CN)-N-boolean AND)(2)((NN)-N-boolean AND-LA)]PF6 ((CN)-N-boolean AND = 2-phenylpyridine). Even though both complexes were constructed based on the same (NN)-N-boolean AND-LA ligand, Ir1 showed no cytotoxicity (IC50 > 200 mu M), which was due to its low lipophilicity for hard penetration into the cancer cells, easy hydrolysis, and reaction with GSH. Ir2 exhibited excellent cytotoxicity (IC50 = 3.43-6.74 mu M) toward diverse cancer cell lines in vitro and a promising ability to overcome the cisplatin-resistance in A549R cells. The anticancer mechanism of Ir2 in A549 cells was investigated in detail, and it was found it could localize and accumulate in the lysosomes of A549 cells, induce ROS, arrest the cycle at G(0)/G(1), and lead to cell death by autophagy. Comparison with Ir-NH2 ([Ir((CN)-N-boolean AND)(2)((NN)-N-boolean AND-NH2)]PF6) demonstrated that introduction of the LA ligand to Ir2 could highly enhance the cytotoxicity and help to overcome the cisplatin-resistance. This study of the half-sandwich and cyclometalated Ir(iii)-based anticancer agents highlighted the different MoAs toward cancer cells and provided new insights for understanding their structure-property relationships.

文章链接：

https://pubs.rsc.org/en/content/articlelanding/2020/RA/C9RA10357K#!divAbstract

版权与免责声明：本网页的内容由收集互联网上公开发布的信息整理获得。目的在于传递信息及分享，并不意味着赞同其观点或证实其真实性，也不构成其他建议。仅提供交流平台，不为其版权负责。如涉及侵权，请联系我们及时修改或删除。邮箱：sales@allpeptide.com